Personalized immunotherapies using onconatigen/neoantigen-reactive TCR-engineered T cells

被引：0
|
作者：
Matsuda, Tatsuo [1 ]
Kato, Taigo [1 ]
Ikeda, Yuji [1 ]
Leisegang, Matthias [2 ]
Hikichi, Tetsuro [3 ]
Harada, Makiko [1 ]
Zewde, Makda [1 ]
Park, Jae-Hyun [1 ]
Kiyotani, Kazuma [1 ]
Nakamura, Yusuke [1 ]
机构：
[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[2] Charite, Inst Immunol, Campus Buch, Berlin, Germany
[3] OncoTherapy Sci Inc, Kawasaki, Kanagawa, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Personalized immunotherapy; neoantigen;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3002
引用
收藏
页码：837 / 837
页数：1
相关论文
共 50 条
  • [31] Immunotherapy with TCR-Redirected T Cells: Comparison of TCR-Transduced and TCR-Engineered Hematopoietic Stem Cell-Derived T Cells
    Staerck, Lilian
    Popp, Katja
    Pircher, Hanspeter
    Uckert, Wolfgang
    JOURNAL OF IMMUNOLOGY, 2014, 192 (01): : 206 - 213
  • [32] CD39 deletion in TCR-engineered T cells enhances antitumour immunity
    Tsai, Alexander K.
    Stromnes, Ingunn M.
    GUT, 2023,
  • [33] Neoantigen-reactive T cell: An emerging role in adoptive cellular immunotherapy
    Zhu, Yicheng
    Qian, Youkun
    Li, Zhile
    Li, Yangyang
    Li, Bin
    MEDCOMM, 2021, 2 (02): : 207 - 220
  • [34] Automated, closed, GMP-compliant manufacture of TCR-engineered T cells for therapy
    Ogusuku, I. Elias Yonezawa
    Lennartz, S.
    Brandes, C.
    Herbel, V.
    Teppert, K.
    Schaser, T.
    Koutsoumpli, G.
    Griffioen, G.
    Johnston, I.
    Lock, D.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A102 - A102
  • [35] Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single Cells
    Paria, Biman C.
    Levin, Noam
    Lowery, Frank J.
    Pasetto, Anna
    Deniger, Drew C.
    Parkhurst, Maria R.
    Yossef, Rami
    Kim, Sanghyun P.
    Florentin, Maria
    Ngo, Lien T.
    Ray, Satyajit
    Krishna, Sri
    Robbins, Paul F.
    Rosenberg, Steven A.
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (01) : 1 - 8
  • [36] NEOANTIGEN-ENGINEERED IPSCS-BASED CANCER VACCINE ENHANCES NEOANTIGEN-REACTIVE T CELL RESPONSE TO BENEFIT THE THERAPEUTIC EFFICACY OF RADIOTHERAPY
    Huang, K.
    Chao, K.
    Chen, W.
    Ke, T.
    Liang, J.
    Lai, C.
    Hung, W.
    Chang, H.
    Yang, P.
    Shiau, A.
    CYTOTHERAPY, 2023, 25 (06) : S277 - S278
  • [37] Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma
    Leko, Vid
    Cafri, Gal
    Yossef, Rami
    Paria, Biman
    Hill, Victoria
    Gurusamy, Devikala
    Zheng, Zhili
    Gartner, Jared J.
    Prickett, Todd D.
    Goff, Stephanie L.
    Robbins, Paul
    Lu, Yong-Chen
    Rosenberg, Steven A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [38] Unveiling the immunological landscape: comprehensive characterization of neoantigen-reactive immune cells in neoantigen cancer vaccines
    Liu, Weijiang
    Su, Hong
    Guo, Peng
    Hong, Liping
    Hao, Xishan
    Li, Xiaoling
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [39] Identification of neoantigen-reactive T cells in head and neck cancer through genomics and immunogenomics analyses
    Lili, Ren
    Park, Jae Hyun
    Kato, Taigo
    Matsuda, Tatsuo
    Saloura, Vassiliki
    Seiwert, Tanguy Lin
    Vokes, Everette
    Agrawal, Nishant
    Nakamura, Yusuke
    CANCER SCIENCE, 2018, 109 : 293 - 293
  • [40] Neoantigen-reactive T cells combined with chemotherapy and radiation improved survival in advanced pancreatic cancer
    Liu, Q.
    Kong, W.
    Chen, F.
    Meng, F.
    Wei, J.
    Zou, Z.
    Liu, B.
    ANNALS OF ONCOLOGY, 2019, 30
12345